What Researchers Did
Researchers conducted a retrospective analysis of 42 patients with necrotizing soft tissue infections treated with adjunctive hyperbaric oxygen therapy (HBO2) to assess its efficacy and safety.
What They Found
The study reported an overall mortality rate of 11.9% (5 patients) and a morbidity rate of 5% among patients receiving adjunctive HBO2. No amputations occurred at the facility during HBO2 treatment, and the infectious process was controlled after an average of 7 HBO2 treatments. Complications were mild, with ear barotrauma in 3 patients (7%) and confinement anxiety in 17 patients (41%).
What This Means for Canadian Patients
Canadian patients with necrotizing fasciitis may benefit from adjunctive hyperbaric oxygen therapy (HBO2) as part of an aggressive treatment plan, potentially reducing mortality and the need for amputation. This approach could offer a valuable addition to standard care, improving outcomes for a severe and life-threatening condition.
Canadian Relevance
This study was not conducted in Canada and does not have a direct Canadian connection.
Study Limitations
As a retrospective analysis, this study is limited by its observational nature, potential for selection bias, and lack of a control group for direct comparison.